Spine
FDA clears AccuLIF XL spinal fusion device from CoAlign Innovations
CoAlign Innovations landed a nod from federal regulators for the XL version of its AccuLIF device, used during spine fusion surgeries.
CoAlign’s interbody implant is used during the lateral approach to spine surgery, a less-invasive method than traditional posterior fusion or anterior fusion techniques. During lateral surgery, the AccuLIF device is placed inside the target spine section before expanding to create an accurate reconstruction of proper spine anatomy, according to a press release.
NuVasive expands in the U.K., seeks larger facility
Spinal surgery devices maker NuVasive Inc. (NSDQ:NUVA) is heading to a new U.K. office as the company anticipates taking more share in markets across Northern Europe.
Ortho Kinematics’ back diagnostic device lands expanded clearance
With a new 510(k) clearance from the FDA in hand, Ortho Kinematics can offer its Vertebral Motion Analysis spine diagnostic test to patients with neck problems.
FDA approves LDR’s cervical disc replacement device
Austin, Tex.-based LDR landed its 1st FDA approval for its Mobi-C device, a cervical disc replacement for patients with degenerative disc disease.
The privately held company, which was founded in France but is headquartered in Texas, is marketing the product as better alternative to a last-resort procedure called anterior cervical discectomy fusion, which fuses the vertebra to ease painful symptoms of a herniated disk.
Boston Scientific battles whistleblowers in spinal stimulation lawsuit
Boston Scientific (NYSE:BSX) hopes to end a years-long whistleblower lawsuit by barring certain evidence from use, alleging that the former employees who exposed the documents breached their employee contracts by leaking confidential information.
Conflicting decisions and new tactics in Medtronic Infuse lawsuits
Stryker’s spine unit launches 2 new products following FDA clearance
Medtronic rolls out MRI-safe spinal stimulator for chronic pain
Legal loss pushes Globus Medical’s Q2 earnings down
Globus Medical (NYSE:GMED) shares rose more than 2% last week despite a 61% 2nd-quarter profit slide after the medical device company reported earnings above Wall Street’s forecast and confirmed its outlook for the rest of the year.
Mako Surgical surges on strong Q2 numbers
Mako Surgical (NSDQ:MAKO) shares are up nearly 16% so far this morning after the medical device company reported 2nd-quarter numbers that shattered expectations on Wall Street.